ASSOBRAFIR Ciência
https://assobrafirciencia.org/article/doi/10.47066/21779333.AC.2020.0034
ASSOBRAFIR Ciência
Original Research

Adductor pollicis muscle thickness and the nutritional and functional status in individuals with COPD submitted to pulmonary rehabilitation: a pilot study

Luana Redel de Moraes, Ana Amélia Machado Duarte, Gustavo Pereira Reinaldo, Pedro Dal Lago, Cintia Pereira de Araujo

Downloads: 1
Views: 488

Abstract

Background: Loss of muscle mass is an important manifestation in chronic obstructive pulmonary disease (COPD), affecting functional status. In this context, the adductor pollicis muscle thickness (APMT) has been shown to be a useful screening tool for nutritional disorders in hospitalized patients. Aim: To investigate the relationship between APMT and the nutritional and functional status in patients with COPD, as well as to investigate the effects of pulmonary rehabilitation (PR) on APMT. Methods: Patients with COPD were assessed for nutritional status [body mass index, APMT, abdominal and mid-upper arm circumference] and for functional status [limitations in activities of daily living (ADL) and functional capacity assessed by the 6-minute walking test and Glittre-ADL test] and engaged a PR program. Results: Fifteen patients [63.5 ± 7.4 years and forced expiratory volume in one second (FEV1 ): 33.4 ± 15.3% predicted] were included. APMT showed correlation with FEV1 (r = 0.68; p < 0.01), with the limitation in ADL (r = 0.62; p < 0.05) and with mid-upper arm circumference (r = 0.54; p = 0.039) at baseline. Functional capacity and limitation in ADL improved after PR (p < 0.05). APMT was the only nutritional status variable that changed after PR (pre: 11.7 ± 2.5 mm vs. post: 12.5 ± 1.8 mm; p < 0.05). Conclusion: It is not clear if APMT reflects the nutritional and functional status of patients with COPD. Meanwhile, it may be a responsive tool for muscle mass assessment in this population.

Keywords

Chronic Obstructive Pulmonary Disease; Nutritional Status; Anthropometry; Functional Status; Exercise Therapy

Referências

1. Choudhury G, Rabinovich R, MacNee W. Comorbidities and systemic effects of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):10130. http://dx.doi. org/10.1016/j.ccm.2013.10.007. PMid:24507840.

2. Vermeeren MAP, Creutzberg EC, Schols AMWJ, Postma DS, Pieters WR, Roldaan AC,  et  al. Prevalence of nutritional depletion in a large outpatient population of patients with COPD. Respir Med. 2006;100(8):134955. http://dx.doi. org/10.1016/j.rmed.2005.11.023. PMid:16412624.

3. Humphreys K, Cross G, Frith P, Cafarella P. Nutritional status and dietary intake of outpatients with chronic obstructive pulmonary disease. Nutr Diet. 2008;65(2):16874. http:// dx.doi.org/10.1111/j.17470080.2008.00235.x.

4. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest. 2007;132(1):1649. http://dx.doi.org/10.1378/chest.062789. PMid:17505043.

5. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W, Muscaritoli M,  et  al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(6):150420. http://dx.doi. org/10.1183/09031936.00070914. PMid:25234804.

6. Cederholm T, Bosaeus I, Barazzoni R, Bauer J, van Gossum A, Klek S, et al. Diagnostic criteria for malnutrition: an ESPEN Consensus Statement. Clin Nutr. 2015;34(3):33540. http:// dx.doi.org/10.1016/j.clnu.2015.03.001. PMid:25799486.

7. WHO: World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1452. PMid:8594834.

8. Lameu EB, Gerude MF, Campos AC, Luiz RR. The thickness of the adductor pollicis muscle reflects the muscle compartment and may be used as a new anthropometric parameter for nutritional assessment. Curr Opin Clin Nutr Metab Care. 2004;7(3):293301. http://dx.doi.org/10.1097/0 007519720040500000009. PMid:15075921.

9. Gonzalez MC, Duarte RRP, Orlandi SP, Bielemann RM, BarbosaSilva TG. Adductor pollicis muscle: a study about its use as a nutritional parameter in surgical patients. Clin Nutr. 2015;34(5):10259. http://dx.doi.org/10.1016/j. clnu.2014.11.006. PMid:25467064.

10. Ghorabi S, Ardehali H, Amiri Z, Shariatpanahi ZV. Association of the adductor pollicis muscle thickness with clinical outcomes in intensive care unit patients. Nutr Clin Pract. 2016;31(4):5236. http://dx.doi. org/10.1177/0884533615621547. PMid:26869610.

11. Valente KP, Almeida BL, Lazzarini TR, Souza VF, Ribeiro T SC, Moraes RAG, et al. Association of Adductor Pollicis Muscle Thickness and Handgrip Strength with nutritional status in cancer patients. PLoS One. 2019;14(8):e0220334. http:// dx.doi.org/10.1371/journal.pone.0220334.

12. Pereira RA, Caetano AL, Cuppari L, Kamimura MA. Adductor pollicis muscle thickness as a predictor of handgrip strength in hemodialysis patients. J Bras Nefrol. 2013;35(3):17784. http:// dx.doi.org/10.5935/01012800.20130029. PMid:24100736.

13. GOLD. Global strategy for the diagnosis, management, and prevention of COPD. COPD Report. 2020;16(2)

14. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):31938. http://dx.doi.org/10.1183/09031936.05. 00034805. PMid:16055882.

15. Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007;33(4):397406. http://dx.doi.org/10.1590/ S180637132007000400008. PMid:17982531.

16. Schols AMWJ, Broekhuizen R, WelingScheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):539. http:// dx.doi.org/10.1093/ajcn/82.1.53. PMid:16002800.

17. Frisancho A. Anthropometric standards for the assessment of growth and nutritional status. anthropometric standards for the assessment of growth and nutritional Status. Ann Arbor: University of Michigan Press; 1990. http://dx.doi. org/10.3998/mpub.12198.

18. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):142846.

19. Britto RR, Probst VS, Andrade AFD, Samora GAR, Hernandes NA, Marinho PEM,  et  al. Reference equations for the sixminute walk distance based on a Brazilian multicenter study. Braz J Phys Ther. 2013;17(6):55663. http://dx.doi. org/10.1590/S141335552012005000122. PMid:24271092.

20. Skumlien S, Hagelund T, Bjortuft O, Ryg MS. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med. 2006;100(2):31623. http:// dx.doi.org/10.1016/j.rmed.2005.04.022. PMid:15941658.

21. Reis CM, Karloh M, Fonseca FR, Biscaro RRM, Mazo GZ, Mayer AF. Functional capacity measurement: reference equations for the Glittre Activities of Daily Living test. J Bras Pneumol. 2018;44(5):3707. http://dx.doi.org/10.1590/ s180637562017000000118. PMid:30020345.

22. Garrod R, Paul EA, Wedzicha JA. An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL). Respir Med. 2002;96(9):72530. http:// dx.doi.org/10.1053/rmed.2002.1338. PMid:12243319.

23. Spruit MA, Singh SJ, Garvey C, Zuwallack R, Nici L, Rochester C, et al. An official American Thoracic Society/ European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e1364. http://dx.doi.org/10.1164/ rccm.2013091634ST. PMid:24127811.

24. O’Connor R, Simmons J, O’Shea P. Weight Training Today. St Paul: West Publishing; 1989.

25. Thompson WR, Gordon NF, Pescatello LS. ACSM’s guidelines for exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins; 2009.

26. Creutzberg EC, Wouters EFM, Mostert R, Pluymers RJ, Schols AMWJ. A role for anabolic steroids in the rehabilitation of patients with COPD? *. Chest. 2003;124(5):173342. http:// dx.doi.org/10.1378/chest.124.5.1733.PMid:14605042.

27. Casaburi R, Bhasin S, Cosentino L, Porszasz J, Somfay A, Lewis MI,  et  al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(8):8708. http://dx.doi. org/10.1164/rccm.200305617OC. PMid:15271690.

28. Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Bérubé C,  et  al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(3):896901. http://dx.doi.org/10.1164/ ajrccm.159.3.9807034. PMid:10051269.

29. Man WDC, Soliman MG, Nikoletou D, Harris ML, Rafferty GF, Mustfa N, et al. Nonvolitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax. 2003;58(8):6659. http://dx.doi.org/10.1136/ thorax.58.8.665. PMid:12885979.

30. Mador MJ, Dahuja M. Mechanisms for diaphragmatic fatigue following highintensity leg exercise. Am J Respir Crit Care Med. 1996;154(5):14849. http://dx.doi.org/10.1164/ ajrccm.154.5.8912769. PMid:8912769.

31. Bielemann RM, Horta BL, Orlandi SP, BarbosaSilva TG, Gonzalez MC, Assunção MC,  et  al. Is adductor pollicis muscle thickness a good predictor of lean mass in adults? Clin Nutr. 2016;35(5):10737. http://dx.doi.org/10.1016/j. clnu.2015.07.022. PMid:26286900.

32. Engelen MP, Schols AM, Lamers RJ, Wouters EF. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr. 1999;18(5):27580. http://dx.doi.org/10.1016/ S02615614(98)800241. PMid:10601534.

33. Steuten LMG, Creutzberg EC, Vrijhoef HJM, Wouters EF. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J. 2006;15(2):8491. http://dx.doi. org/10.1016/j.pcrj.2005.09.001. PMid:16701766.

34. Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics. 2010;65(6):599605. http://dx.doi.org/10.1590/ S180759322010000600007. PMid:20613936.

35. Schols AM, Mostert R, Soeters PB, Wouters EF. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax. 1991;46(10):6959. http://dx.doi.org/10.1136/thx.46.10.695. PMid:1750015.

36. Wüst RCI, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis. 2007;2(3):289300. PMid:18229567.

37. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest. 2005;128(1):629. http://dx.doi.org/10.1378/chest.128.1.62.PMid:16002917.

38. Creutzberg EC, Schols AMWJ, WelingScheepers CAPM, Buurman WA, Wouters EFM. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(3):74552. http://dx.doi.org/10.1164/ ajrccm.161.3.9808075. PMid:10712317.

39. Maatman RC, Spruit MA, van Melick PP, Peeters JPI, Rutten EPA, Vanfleteren LEGW, et al. Effects of obesity on weightbearing versus weightsupported exercise testing in patients with COPD. Respirology. 2016;21(3):4838. http:// dx.doi.org/10.1111/resp.12700. PMid:26647921.

40. Monteiro F, Ponce DAN, Silva H, Carrilho AF, Pitta F. Validity and reproducibility of the Glittre ADLTest in obese and postbariatric surgery patients. Obes Surg. 2017;27(1):1104. http://dx.doi.org/10.1007/s1169501622447. PMid:27317008.


Submetido em:
11/05/2021

Aceito em:
02/10/2021

618b9f65a953951d4d1a1dd4 assobrafir Articles
Links & Downloads

ASSOBRAFIR Ciência

Share this page
Page Sections